Profile data is unavailable for this security.
About the company
Portage Biotech Inc. is a Canada-based clinical-stage immuno-oncology company. The Company is advancing therapies to improve long-term treatment response and quality of life in patients with evasive cancers. The Company’s access to technologies coupled with a deep understanding of biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of six diverse platforms, with programs including invariant natural killer T cell (iNKT) agonists, which includes PORT-2 and PORT-3, therapies that activate the innate and adaptive immune system. Its portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent of targeting the adenosine pathway. Within these six platforms, the Company has 14 products in development with multiple clinical readouts.
- Revenue in USD (TTM)0.00
- Net income in USD-17.48m
- Incorporated--
- Employees6.00
- LocationPortage Biotech Inc47 Avenue Rd Suite 200TORONTO M5R 2G3CanadaCAN
- Phone+1 (416) 929-1806
- Fax+1 (416) 929-6612
- Websitehttps://portagebiotech.com/
More ▼
Mergers & acquisitions
| Acquired company | PRTG:NAQ since announced | Transaction value |
|---|---|---|
| iOx Therapeutics Ltd | -71.44% | 35.07m |
Data delayed at least 15 minutes, as of Mar 24 2023 19:49 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | 13.48m | -96.78m | 42.80m | 56.00 | -- | 0.7723 | -- | 3.17 | -2.34 | -2.34 | 0.3241 | 1.25 | 0.1094 | 0.6723 | 6.24 | 240,785.70 | -78.51 | -56.95 | -101.06 | -67.83 | 86.38 | -- | -717.71 | -1,242.44 | 4.57 | -30.41 | 0.4174 | -- | 11.05 | -- | -185.33 | -- | 50.52 | -- |
| Synlogic Inc | 1.67m | -64.54m | 42.98m | 84.00 | -- | 0.4266 | -- | 25.80 | -0.8954 | -0.8954 | 0.0231 | 1.43 | 0.0105 | -- | 1.33 | 19,833.33 | -40.49 | -38.80 | -43.52 | -41.38 | -- | -- | -3,873.95 | -2,739.74 | -- | -- | 0.0002 | -- | 221.83 | 31.62 | -2.35 | -- | -18.09 | -- |
| Genprex Inc | 0.00 | -22.66m | 43.66m | 17.00 | -- | 1.47 | -- | -- | -0.473 | -0.473 | 0.00 | 0.5724 | 0.00 | -- | -- | 0.00 | -59.41 | -94.20 | -62.37 | -98.73 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.21 | -- | -4.15 | -- |
| Taysha Gene Therapies Inc | 0.00 | -160.68m | 43.70m | 178.00 | -- | 2.59 | -- | -- | -4.12 | -4.12 | 0.00 | 0.2702 | 0.00 | -- | -- | 0.00 | -91.16 | -- | -116.37 | -- | -- | -- | -- | -- | -- | -43.46 | 0.7725 | -- | -- | -- | -190.82 | -- | -- | -- |
| LifeVantage Corp | 206.38m | -723.00k | 43.75m | 259.00 | -- | 1.37 | 15.95 | 0.212 | -0.0699 | -0.0699 | 16.49 | 2.51 | 2.95 | 2.27 | 85.56 | 796,841.70 | -1.03 | 13.96 | -1.53 | 23.79 | 80.28 | 82.82 | -0.3503 | 3.87 | 1.03 | 28.39 | 0.00 | -- | -6.28 | 0.6796 | -75.80 | 14.18 | 7.72 | -- |
| Hookipa Pharma Inc | 14.25m | -64.92m | 44.08m | 156.00 | -- | 0.4299 | -- | 3.09 | -1.29 | -1.29 | 0.2669 | 1.87 | 0.0961 | -- | 2.12 | 91,339.74 | -43.79 | -37.65 | -55.67 | -44.36 | -- | -- | -455.58 | -339.50 | -- | -- | 0.0239 | -- | -22.76 | -- | 14.21 | -- | 31.07 | -- |
| Know Labs Inc | 8.69k | -18.54m | 44.35m | 19.00 | -- | 6.33 | -- | 5,103.16 | -0.4356 | -0.4356 | 0.0002 | 0.1453 | 0.0007 | -- | -- | 543.13 | -144.85 | -234.54 | -821.31 | -- | -- | -- | -213,319.80 | -659.70 | -- | -4.08 | 0.2435 | -- | -- | -2.21 | 20.86 | -- | -- | -- |
| Portage Biotech Inc | 0.00 | -17.48m | 44.37m | 6.00 | -- | 0.2627 | -- | -- | -1.17 | -1.17 | 0.00 | 9.90 | 0.00 | -- | -- | 0.00 | -9.38 | 11.61 | -10.65 | 15.79 | -- | -- | -- | -- | -- | -85.40 | 0.00 | -- | -- | -- | -6.55 | -- | -- | -- |
| Beyondspring Inc | 1.35m | -64.18m | 44.41m | 103.00 | -- | 1.66 | -- | 32.87 | -1.64 | -1.64 | 0.0346 | 0.6855 | 0.0136 | -- | -- | 13,116.50 | -68.66 | -130.61 | -81.89 | -169.71 | -- | -- | -5,048.71 | -21,307.90 | -- | -- | 0.0561 | -- | 650.56 | -- | -5.26 | -- | 113.57 | -- |
| Movano Inc | 0.00 | -28.71m | 44.43m | 27.00 | -- | 3.02 | -- | -- | -0.8746 | -0.8746 | 0.00 | 0.4376 | 0.00 | -- | -- | 0.00 | -94.08 | -- | -106.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -10.56 | -- | -- | -- |
| NextCure Inc | 0.00 | -74.73m | 44.72m | 99.00 | -- | 0.2669 | -- | -- | -2.69 | -2.69 | 0.00 | 6.03 | 0.00 | -- | -- | 0.00 | -35.04 | -20.55 | -36.38 | -21.45 | -- | -- | -- | -825.97 | -- | -- | 0.00 | -- | -- | -- | -7.70 | -- | -24.55 | -- |
| Praxis Precision Medicines Inc | 0.00 | -214.03m | 44.73m | 109.00 | -- | 0.554 | -- | -- | -4.66 | -4.66 | 0.00 | 1.54 | 0.00 | -- | -- | 0.00 | -104.95 | -- | -127.74 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -28.11 | -- | -- | -- |
| Aquestive Therapeutics Inc | 47.68m | -54.41m | 44.96m | 157.00 | -- | -- | -- | 0.9429 | -1.14 | -1.14 | 0.9793 | -2.16 | 0.8104 | 3.95 | 5.67 | -- | -92.48 | -90.80 | -194.23 | -141.76 | 59.34 | 66.46 | -114.11 | -116.62 | 0.8596 | -3.41 | -- | -- | -6.20 | -6.55 | 22.87 | -- | -- | -- |
| Psycheceutical Bioscience Inc | 1.16m | -149.52k | 46.21m | 28.00 | -- | 0.5295 | -- | 39.94 | -0.1157 | -0.1157 | 0.8953 | 0.3399 | 0.6308 | 98.60 | 2.34 | 41,318.93 | -8.15 | -19.61 | -29.82 | -55.36 | 60.50 | 39.98 | -12.92 | -43.93 | 0.959 | -- | 0.0906 | -- | -30.52 | 83.37 | 43.79 | -- | -- | -- |
Data as of Mar 24 2023. Currency figures normalised to Portage Biotech Inc's reporting currency: US Dollar USD
0.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MAI Capital Management LLCas of 31 Dec 2022 | 57.51k | 0.34% |
| BlackRock Fund Advisorsas of 31 Dec 2022 | 27.82k | 0.16% |
| Dimensional Fund Advisors LPas of 31 Dec 2022 | 18.33k | 0.11% |
| Sigma Planning Corp.as of 31 Dec 2022 | 11.86k | 0.07% |
| Ergoteles LLCas of 31 Dec 2022 | 10.85k | 0.06% |
| Advisor Partners II LLCas of 31 Dec 2022 | 10.10k | 0.06% |
| Pathstone Family Office LLCas of 31 Dec 2022 | 10.10k | 0.06% |
| Barclays Bank Plc (Private Banking)as of 31 Dec 2022 | 5.66k | 0.03% |
| Tower Research Capital LLCas of 31 Dec 2022 | 2.84k | 0.02% |
| Morgan Stanley & Co. LLCas of 31 Dec 2022 | 2.67k | 0.02% |
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
